EQ Wealth Advisors’s Organon & Co OGN Stock Holding History

EQ Wealth Advisors’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-17	Closed	-$253	–	278
2025 Q1	$253	Buy	+17	New	+$261	﹤0.01%	261

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

EQ Wealth Advisors's OGN Position: Q2 2025 in Review

EQ Wealth Advisors sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 17 shares — an estimated $253 sold.

EQ Wealth Advisors first reported a position in OGN in Q1 2025 and held it in 1 quarter. The position peaked at $253 in Q1 2025. 696 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

EQ Wealth Advisors reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
EQ Wealth Advisors sold 17 Organon & Co shares in Q2 2025, an estimated $253.
EQ Wealth Advisors first reported a position in Organon & Co in Q1 2025 and held it in 1 quarter.
EQ Wealth Advisors's Organon & Co position peaked at $253 in Q1 2025.
696 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on EQ Wealth Advisors's 13F filing for Q2 2025, filed 28 Jul 2025.